-
1
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
-
discussion 318-321
-
Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318, 1999; discussion 318-321
-
Ann Surg
, vol.230
, Issue.309-318
, pp. 1999
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
-
3
-
-
0030973169
-
Hepatic resection for metastatic colorectal cancer results in cure for some patients
-
discussion 511
-
Jamison RL, Donohue JH, Nagorney DM, et al: Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132:505-510, 1997; discussion 511
-
Arch Surg
, vol.132
, Issue.505-510
, pp. 1997
-
-
Jamison, R.L.1
Donohue, J.H.2
Nagorney, D.M.3
-
4
-
-
0032815641
-
Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer: Too good to be true?
-
Borner MM: Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer: Too good to be true? Ann Oncol 10:623-626, 1999
-
(1999)
Ann Oncol
, vol.10
, pp. 623-626
-
-
Borner, M.M.1
-
5
-
-
0024390441
-
Resection of hepatic metastases from colorectal cancer: Biologic perspective
-
Steele G Jr, Ravikumar TS: Resection of hepatic metastases from colorectal cancer: Biologic perspective. Ann Surg 210:127-138, 1989
-
(1989)
Ann Surg
, vol.210
, pp. 127-138
-
-
Steele Jr, G.1
Ravikumar, T.S.2
-
6
-
-
0036104072
-
Trends in long-term survival following liver resection for hepatic colorectal metastases
-
Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766, 2002
-
(2002)
Ann Surg
, vol.235
, pp. 759-766
-
-
Choti, M.A.1
Sitzmann, J.V.2
Tiburi, M.F.3
-
7
-
-
0031307908
-
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer
-
D'Angelica M, Brennan MF, Fortner JG, et al: Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 185:554-559, 1997
-
(1997)
J Am Coll Surg
, vol.185
, pp. 554-559
-
-
D'Angelica, M.1
Brennan, M.F.2
Fortner, J.G.3
-
8
-
-
0017172793
-
A retrospective study of the natural history of patients with liver metastases from colorectal cancer
-
Wood CB, Gillis CR, Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285-288, 1976
-
(1976)
Clin Oncol
, vol.2
, pp. 285-288
-
-
Wood, C.B.1
Gillis, C.R.2
Blumgart, L.H.3
-
9
-
-
0021282270
-
The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment
-
Wagner JS, Adson MA, Van Heerden JA, et al: The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment. Ann Surg 199:502-508, 1984
-
(1984)
Ann Surg
, vol.199
, pp. 502-508
-
-
Wagner, J.S.1
Adson, M.A.2
Van Heerden, J.A.3
-
10
-
-
13744251436
-
Systemic therapy for colorectal cancer
-
Meyerhardt JA, Mayer RJ: Systemic therapy for colorectal cancer. N Engl J Med 352:476-487, 2005
-
(2005)
N Engl J Med
, vol.352
, pp. 476-487
-
-
Meyerhardt, J.A.1
Mayer, R.J.2
-
11
-
-
0142162682
-
Natural history of liver metastases from colorectal carcinoma
-
Norstein J, Silen W: Natural history of liver metastases from colorectal carcinoma. J Gastrointest Surg 1:398-407, 1997
-
(1997)
J Gastrointest Surg
, vol.1
, pp. 398-407
-
-
Norstein, J.1
Silen, W.2
-
12
-
-
0024460951
-
Hepatic resection for metastases from colorectal carcinoma is of dubious value
-
Silen W: Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 124:1021-1022, 1989
-
(1989)
Arch Surg
, vol.124
, pp. 1021-1022
-
-
Silen, W.1
-
13
-
-
0023161984
-
Resection of liver metastases: When is it worthwhile?
-
Adson MA: Resection of liver metastases: When is it worthwhile? World J Surg 11:511-520, 1987
-
(1987)
World J Surg
, vol.11
, pp. 511-520
-
-
Adson, M.A.1
-
14
-
-
2442763386
-
Nonparametric estimation from incomplete observations
-
Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 8:423-446, 1958
-
(1958)
J Am Stat Assoc
, vol.8
, pp. 423-446
-
-
Kaplan, E.1
Meier, P.2
-
15
-
-
0013886333
-
Evaluation of survival data and two new rank order statistics arising in its consideration
-
Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 163-170
-
-
Mantel, N.1
-
16
-
-
0034727063
-
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group
-
Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group. N Engl J Med 343:905-914, 2000
-
(2000)
N Engl J Med
, vol.343
, pp. 905-914
-
-
Saltz, L.B.1
Cox, J.V.2
Blanke, C.3
-
17
-
-
0033874892
-
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
-
de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 2938-2947
-
-
de Gramont, A.1
Figer, A.2
Seymour, M.3
-
18
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, R.M.1
Sargent, D.J.2
Morton, R.F.3
-
19
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
20
-
-
0033619892
-
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
-
Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999
-
(1999)
N Engl J Med
, vol.341
, pp. 2039-2048
-
-
Kemeny, N.1
Huang, Y.2
Cohen, A.M.3
-
21
-
-
33645450153
-
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
-
Kemeny NE, Niedzwiecki D, Hollis DR, et al: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395-1403, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 1395-1403
-
-
Kemeny, N.E.1
Niedzwiecki, D.2
Hollis, D.R.3
-
22
-
-
30144435398
-
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
-
Karoui M, Penna C, Amin-Hashem M, et al: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7, 2006
-
(2006)
Ann Surg
, vol.243
, pp. 1-7
-
-
Karoui, M.1
Penna, C.2
Amin-Hashem, M.3
|